Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.38 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.36 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.36 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 3/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.33 |
| ▸ | EPAS1 | Q99814 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | CES2 | O00748 | 1/20 | 0.33 |
| ▸ | KDM1A | O60341 | 1/20 | 0.33 |
| ▸ | EED | O75530 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12602809 | 0.91 | CA2 (0.38) | MAPTKDM4EALDH1A1GABRA1GABRB2 | |
| SCHEMBL17278051 | 0.85 | CA2 (0.43) | MAPTALDH1A1GABRA1GABRB2TDP1 | |
| SCHEMBL9270026 | 0.80 | DHFR (0.42) | CYP1A2CYP2A6KDM4EALDH1A1SLC22A12 | |
| SCHEMBL16852471 | 0.79 | CYP1A2 (0.56) | CYP1A2CYP2A6MAPTKDM4EALDH1A1 | |
| SCHEMBL12602812 | 0.77 | CA2 (0.39) | CYP1A2MAPTKDM4EALDH1A1GABRA1 | |
| SCHEMBL12650307 | 0.75 | MYC (0.30) | — | |
| SCHEMBL2380918 | 0.74 | CYP1A2 (0.68) | CYP1A2CYP2A6MAPTKDM4EPABPC1 | |
| SCHEMBL29416731 | 0.74 | CYP1A2 (0.68) | CYP1A2CYP2A6MAPTKDM4EPABPC1 | |
| SCHEMBL260441 | 0.74 | CYP1A2 (0.68) | CYP1A2CYP2A6MAPTKDM4EPABPC1 | |
| SCHEMBL28836547 | 0.73 | CYP1A2 (0.54) | CYP1A2CYP2A6MAPTKDM4EPABPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2340290-B1 | NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES | MERCK PATENT GMBH (DE) | 2015-11-25 | — | — | EP | disclosed |
| EP-2340290-B1 | NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES | MERCK PATENT GMBH (DE) | 2015-11-25 | — | — | EP | disclosed |
| US-8901298-B2 | Materials for organic electroluminescence devices | MERCK PATENT GMBH (DE) | 2014-12-02 | — | — | US | disclosed |
| US-8901298-B2 | Materials for organic electroluminescence devices | MERCK PATENT GMBH (DE) | 2014-12-02 | — | — | US | disclosed |
| US-8901298-B2 | Materials for organic electroluminescence devices | MERCK PATENT GMBH (DE) | 2014-12-02 | — | — | US | disclosed |
| EP-2340290-A1 | NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES | Merck Patent GmbH (DE) | 2011-07-06 | — | — | EP | disclosed |
| US-20110112275-A1 | NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES | MERCK PATENT GMBH (DE) | 2011-05-12 | — | — | US | disclosed |
| US-20110112275-A1 | NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES | MERCK PATENT GMBH (DE) | 2011-05-12 | — | — | US | disclosed |
| US-20110112275-A1 | NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES | MERCK PATENT GMBH (DE) | 2011-05-12 | — | — | US | disclosed |
| WO-2010049050-A1 | NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES | MERCK PATENT GMBH (DE) | 2010-05-06 | — | — | WO | disclosed |
| WO-2010049050-A1 | NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES | MERCK PATENT GMBH (DE) | 2010-05-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110112275-A1 | NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES | LAGE3, EML4, MCM4 | CYP1A2 1092/4885CYP2A6 3166/4885MAPT 1785/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.